| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 105.573 | 235.608 | 233.709 | 232.788 | 223.313 | 221.952 | 234.242 | 212.668 | 202.848 | 203.059 |
| Total Income - EUR | 105.764 | 235.826 | 233.907 | 232.811 | 223.318 | 226.333 | 230.457 | 212.123 | 204.768 | 203.234 |
| Total Expenses - EUR | 134.110 | 232.458 | 224.065 | 232.403 | 199.534 | 220.791 | 222.443 | 199.558 | 185.925 | 214.144 |
| Gross Profit/Loss - EUR | -28.346 | 3.368 | 9.842 | 409 | 23.784 | 5.543 | 8.014 | 12.565 | 18.843 | -10.910 |
| Net Profit/Loss - EUR | -28.346 | 3.368 | 7.705 | -1.920 | 21.551 | 4.018 | 6.093 | 10.486 | 17.103 | -15.146 |
| Employees | 10 | 10 | 10 | 9 | 9 | 8 | 7 | 7 | 6 | 6 |
Check the financial reports for the company - Al Musawy Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.247 | 904 | 576 | 346 | 181 | 178 | 174 | 174 | 174 | 173 |
| Current Assets | 60.428 | 63.977 | 38.576 | 64.116 | 124.590 | 135.768 | 139.943 | 52.992 | 68.177 | 62.530 |
| Inventories | 57.426 | 49.563 | 29.993 | 25.841 | 38.261 | 41.357 | 27.197 | 20.669 | 48.454 | 52.720 |
| Receivables | 2.271 | 0 | 86 | 2.807 | 4.072 | 2.321 | 3.674 | 5.112 | 4.566 | 3.203 |
| Cash | 731 | 14.415 | 8.497 | 35.468 | 82.257 | 92.090 | 109.072 | 27.211 | 15.157 | 6.607 |
| Shareholders Funds | -52.226 | -48.325 | -39.802 | -40.992 | -18.647 | -14.276 | -7.866 | 2.596 | 19.690 | 4.434 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 117.406 | 116.226 | 81.923 | 108.294 | 146.203 | 152.954 | 150.725 | 53.321 | 48.660 | 58.269 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Al Musawy Med S.r.l.